|
US2021119405A1
|
|
System and method for determining absolute carrier-envelope phase of ultrashort laser pulses
|
|
US2021106571A1
|
|
Isothiocyanate-androgen receptor inhibitor conjugates for apoptosis and/or ferroptosis induction in cancer cells
|
|
WO2021034943A1
|
|
In vivo immunoimaging of interleukin-12
|
|
US2021038687A1
|
|
Compositions and methods relating to a c-terminal peptide of troponin i with activity as a myofilament ca2+ desensitizer
|
|
WO2020237080A1
|
|
Non-invasive mitochondrial modulation therapy for focal stroke
|
|
US2020359887A1
|
|
Oct radiomic features for differentiation of early malignant melanoma from benign nevus
|
|
US2021079856A1
|
|
In situ valuation of auto-ignition quality of fuel in compression ignition engines
|
|
US2020268879A1
|
|
Amphiphilic oligodeoxynucleotide conjugates as adjuvant enhancers
|
|
WO2020118103A1
|
|
Heparanase inhibitors and their use as anti-cancer compounds
|
|
WO2020092729A1
|
|
Light therapy treatment method and apparatus
|
|
US2020121242A1
|
|
Ultrasound, photoacoustic, and viscoelastic imaging systems and methods for cervical analysis to assess risk of preterm delivery
|
|
WO2020069071A1
|
|
A three-phase double t-type four-level rectifier
|
|
US2020077974A1
|
|
Ultrasound and multispectral photoacoustic systems and methods for brain and spinal cord imaging through acoustic windows
|
|
US2020078356A1
|
|
Neuroprotective agents for treatment of neurodegenerative diseases
|
|
WO2020051435A1
|
|
Neuroprotective agents for treatment of neurodegenerative diseases
|
|
US2020062801A1
|
|
Epimerization-free n to c solid-phase peptide synthesis
|
|
WO2020028776A1
|
|
Methods and compositions relating to anti-biotin antibodies
|
|
US2020012008A1
|
|
Parity-time (pt)-symmetric wireless telemetric sensors and systems
|
|
US2020264050A1
|
|
Apparatuses, systems, and methods for detecting materials based on raman spectroscopy
|
|
US2019262462A1
|
|
Iga fc-folate conjugates, pharmaceutical compositions and methods to treat cancer
|
